Boyd Peter E. (CIK 1739816) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-10). Recent activity: Buy AQST (2,293 shares), Sell AQST (56,778 shares), Buy AQST (80,000 shares), Sell AQST (29,814 shares), Buy AQST (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Buy | 2,293 | $2,201 |
| 2026-05-07 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Sell | 56,778 | $237,332 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Buy | 80,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Sell | 29,814 | $124,324 |
| 2025-12-05 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Buy | 20,000 | $0 |
| 2025-10-17 | Aquestive Therapeutics, Inc. (AQST) | SVP IT, HR, & Communications | Sell | 10,000 | $70,000 |
| 2025-09-29 | Aquestive Therapeutics, Inc. (AQST) | SVP IT, HR, & Communications | Sell | 10,000 | $63,000 |
| 2025-09-08 | Aquestive Therapeutics, Inc. (AQST) | SVP IT, HR, & Communications | Sell | 15,000 | $79,500 |
来源：SEC Form 4 申报文件 · 截至 2026-09-10